Core Insights - Guoke Photon (Jinan) Laser Technology Co., Ltd. has signed a seed round equity investment agreement to accelerate the commercialization of its technology [1] - The company focuses on high-end medical equipment development, with its core technology being ultra-broadband tunable laser technology [1] - Guoke Photon has successfully developed the world's first ultra-broadband tunable laser medical device prototype, which is applicable for precise treatment of brain and spinal tumors, liver diseases, and more [1] Investment Details - The investment round is led by Jinan Financial Group's Haiyou Talent Fund, with Tianjin Hongcheng Yizhen Technology participating [1] - The funds will be used for product finalization, preclinical research, and patent layout [1] Company Background - Guoke Photon was established in May 2024 and is incubated by Qilu Zhongke Optics and Engineering Technology Research Institute [1] - The company represents a significant innovation platform for the transformation of research achievements in Jinan [1] - Its business scope includes research and development of electronic special materials, manufacturing and sales of optoelectronic devices, optical instruments, and third-class medical devices [1] - The company possesses full-chain capabilities from core technology research and development to product manufacturing [1]